Overview
BFRI market data
Price History
BFRI price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.04 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.78 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -25.7% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.56 – $1.27 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $15.5M · P/B 0.63 · P/S 0.36.
Company News
Biofrontera Q2 EPS $(0.05) Misses $(0.04) Estimate, Sales $12.003M Beat $10.500M EstimateBenzinga · Aug 13, 2026, 12:54 PM
Photodynamic Therapy Market: Durable Growth with a CAGR of 8.3% Through 2035Globenewswire Inc · Jul 3, 2026, 12:15 PM
This Hanover Insurance Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For TuesdayBenzinga · May 19, 2026, 2:35 PM
This Stubhub Analyst Turns Bullish; Here Are Top 4 Upgrades For TuesdayBenzinga · May 19, 2026, 2:35 PM
Benchmark Downgrades Biofrontera to Speculative Buy, Maintains Price Target to $3Benzinga · May 19, 2026, 12:45 PM
Transcript: Biofrontera Q1 2026 Earnings Conference CallBenzinga · May 14, 2026, 3:39 PM